News
10h
Zacks.com on MSNEMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related ItchGSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking ...
GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved a 200 mg/mL autoinjector of Benlysta, a B-lymphocyte ...
News zur GSK AKTIE und aktueller Realtime-Aktienkurs GSK plc - 6-K, Report of foreign issuer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results